Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults

ByQuantisnow·Wall Street's wire, on your screen.
BMY· Bristol-Myers Squibb Company
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company) and more on Quantisnow.